CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients [Phase 3]
Summary
Phase 3 trial comparing eltrombopag to IVIG before surgery in immune thrombocytopenia patients completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: McMaster University | Conditions: Immune Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED